| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w25483 |
| 来源ID | Working Paper 25483 |
| How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013 | |
| Frank R. Lichtenberg | |
| 发表日期 | 2019-01-28 |
| 出版年 | 2019 |
| 语种 | 英语 |
| 摘要 | We analyze the role that the launch of new drugs has played in reducing the number of years of life lost (YLL) before 3 different ages (85, 70, and 55) due to 66 diseases in 27 countries. We estimate 2-way fixed-effects models of the rate of decline of the disease- and country-specific age-standardized YLL rate. The models control for the average decline in the YLL rate in each country and from each disease. One additional drug launch 0-11 years before year t is estimated to have reduced the pre-age-85 YLL rate (YLL85) in year t by 3.0%, and one additional drug launch 12 or more years before year t is estimated to have reduced YLL85 by 5.5%. (A drug’s utilization peaks 8-10 years after it was launched.) Controlling for the number of drugs previously launched, YLL rates are unrelated to the number of drug classes previously launched. The estimates imply that, if no new drugs had been launched after 1981, YLL85 in 2013 would have been 2.16 times as high as it actually was. We estimate that pharmaceutical expenditure per life-year saved before age 85 in 2013 by post-1981 drugs was $2837. This amount is about 8% of per capita GDP, indicating that post-1981 drugs launched were very cost–effective, overall. But the fact that an intervention is cost-effective does not necessarily mean that it is “affordable.” |
| 主题 | Health, Education, and Welfare ; Health ; Labor Economics ; Demography and Aging ; Development and Growth ; Innovation and R& ; D |
| URL | https://www.nber.org/papers/w25483 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/583157 |
| 推荐引用方式 GB/T 7714 | Frank R. Lichtenberg. How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013. 2019. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w25483.pdf（536KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
| 个性服务 |
| 推荐该条目 |
| 保存到收藏夹 |
| 导出为Endnote文件 |
| 谷歌学术 |
| 谷歌学术中相似的文章 |
| [Frank R. Lichtenberg]的文章 |
| 百度学术 |
| 百度学术中相似的文章 |
| [Frank R. Lichtenberg]的文章 |
| 必应学术 |
| 必应学术中相似的文章 |
| [Frank R. Lichtenberg]的文章 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
